Use of Commercially Available Optically Stimulated Luminescence Dosimeter As Extremity Dose Estimator.

In 2009, Idaho National Laboratory (INL) transitioned to an external dosimetry program using optically stimulated luminescent (OSL) technology. This process led to the introduction of the Landauer, Inc., nanoDot dosimeter and MicroStar reader to INL's radiological control program. At the time, a small, self-contained, single chip OSL dosimeter that could be easily read in the field was recognized as having many potential applications for a radiological control program. The ability to achieve a realistic extremity-dose estimate in the field shortly following work where significant exposure is expected is a much sought-after capability at INL. It was proposed to employ the Landauer nanoDot dosimeter as a supplemental extremity monitor as an alternative to time-motion dose analyses based on direct radiation measurements, which had proven to be inaccurate and operationally inefficient. Additionally, this process does not involve the nanoDot in the US Department of Energy Laboratory Accreditation Program (DOELAP) process, which significantly reduces operational complexity. A dose conversion value for the nanoDot dosimeter was derived from direct comparisons with a DOELAP-accredited extremity dosimeter. The geometry or placement of the nanoDot relative to the accredited extremity dosimeter was kept as proximate as possible to best replicate the expected results from the accredited extremity dosimeter. Upon implementation, the nanoDot has proven to be effective in providing reasonable and timely extremity-dose estimates for operational control.

Investigation and Implementation of Commercially Available Optically Stimulated Luminescence Dosimeters for Use in Fixed Nuclear Accident Dosimeter Systems.

Idaho National Laboratory transitioned from an external dosimetry system reliant on thermoluminescent dosimeters to one that uses optically stimulated luminescence dosimeters in 2010. This change not only affected the dosimeters worn by personnel, but those found in the nuclear-accident dosimeters used across Idaho National Laboratory. The elimination of on-site use and processing of thermoluminescent dosimeters impacted Idaho National Laboratory's ability to process nuclear-accident dosimeters in a timely manner. This change in processes drove Idaho National Laboratory to develop an alternative method for fixed nuclear-accident dosimeter gamma-dose analyses. This new method was driven by the need to establish a simple, cost-effective, and rapid-turnaround alternative to the thermoluminescent-dosimeter-based fixed nuclear-accident dosimeter system. An adaptation of existing technologies proved to be the most efficient path to this end. The purpose of this article is to delineate the technical basis for replacing the thermoluminescent dosimeter contained within the Idaho National Laboratory fixed nuclear-accident dosimeter system with optically stimulated luminescence-based Landauer, Inc., nanoDot dosimeters.